<VariationArchive VariationID="2869078" VariationName="NM_002617.4(PEX10):c.363del (p.Asp122fs)" VariationType="Deletion" Accession="VCV002869078" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2024-02-20" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3027561" VariationID="2869078">
      <GeneList>
        <Gene Symbol="PEX10" FullName="peroxisomal biogenesis factor 10" GeneID="5192" HGNC_ID="HGNC:8851" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="2403974" stop="2413827" display_start="2403974" display_stop="2413827" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="2336240" stop="2344009" display_start="2336240" display_stop="2344009" Strand="-" />
          </Location>
          <OMIM>602859</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002617.4(PEX10):c.363del (p.Asp122fs)</Name>
      <CanonicalSPDI>NC_000001.11:2408688:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="2408689" stop="2408689" display_start="2408689" display_stop="2408689" variantLength="1" positionVCF="2408688" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="2340128" stop="2340128" display_start="2340128" display_stop="2340128" variantLength="1" positionVCF="2340127" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D122fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.2340131del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.2340131del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.2408692del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.2408692del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008342.1" sequenceAccession="NG_008342" sequenceVersion="1" change="g.8883del">
            <Expression>NG_008342.1:g.8883del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_088790.1" sequenceAccession="NG_088790" sequenceVersion="1" change="g.111del">
            <Expression>NG_088790.1:g.111del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374425.1" sequenceAccession="NM_001374425" sequenceVersion="1" change="c.363del">
            <Expression>NM_001374425.1:c.363del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361354.1" sequenceAccession="NP_001361354" sequenceVersion="1" change="p.Asp122fs">
            <Expression>NP_001361354.1:p.Asp122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374426.1" sequenceAccession="NM_001374426" sequenceVersion="1" change="c.-70del">
            <Expression>NM_001374426.1:c.-70del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374427.1" sequenceAccession="NM_001374427" sequenceVersion="1" change="c.-70del">
            <Expression>NM_001374427.1:c.-70del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002617.4" sequenceAccession="NM_002617" sequenceVersion="4" change="c.363del" MANESelect="true">
            <Expression>NM_002617.4:c.363del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002608.1" sequenceAccession="NP_002608" sequenceVersion="1" change="p.Asp122fs">
            <Expression>NP_002608.1:p.Asp122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153818.2" sequenceAccession="NM_153818" sequenceVersion="2" change="c.363del">
            <Expression>NM_153818.2:c.363del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_722540.1" sequenceAccession="NP_722540" sequenceVersion="1" change="p.Asp122fs">
            <Expression>NP_722540.1:p.Asp122fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164636.1" sequenceAccession="NR_164636" sequenceVersion="1" change="n.482del">
            <Expression>NR_164636.1:n.482del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002617.4(PEX10):c.363del (p.Asp122fs) AND Peroxisome biogenesis disorder, complementation group 7" Accession="RCV003653991" Version="1">
        <ClassifiedConditionList TraitSetID="9162">
          <ClassifiedCondition DB="MedGen" ID="C1864399">Peroxisome biogenesis disorder, complementation group 7</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002617.4(PEX10):c.363del (p.Asp122fs) AND Peroxisome biogenesis disorder 6A (Zellweger)" Accession="RCV004573231" Version="1">
        <ClassifiedConditionList TraitSetID="8954">
          <ClassifiedCondition DB="MedGen" ID="C3553947">Peroxisome biogenesis disorder 6A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2024-02-20" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10862081</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9683594</ID>
        </Citation>
        <DescriptionHistory Dated="2024-06-13">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8954" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17434" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 6A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 6A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013936" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD6A</ElementValue>
                <XRef ID="GTR000522761" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614870" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 7 (CG7, equivalent to CGB) have mutations in the PEX10 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614870" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15864" />
                <XRef ID="15864" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553947" DB="MedGen" />
              <XRef ID="MONDO:0013936" DB="MONDO" />
              <XRef Type="MIM" ID="614870" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9162" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16273" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder, complementation group 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder, complementation group B</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CGB</ElementValue>
                <XRef ID="614870" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CG7</ElementValue>
                <XRef ID="614870" DB="OMIM" />
              </Symbol>
              <XRef ID="C1864399" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8259120" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="14919036|MedGen:C1864399" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004472788" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9683594</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10862081</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp122Thrfs*31) in the PEX10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX10 are known to be pathogenic (PMID: 9683594, 10862081, 21031596). This variant has not been reported in the literature in individuals affected with PEX10-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX10" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.2340128del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1864399" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9812896" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_153818.2:c.363del|OMIM:614870" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005055239" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153818.2:c.363del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614870" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8259120" TraitType="Disease" MappingType="XRef" MappingValue="C1864399" MappingRef="MedGen">
        <MedGen CUI="C1864399" Name="Peroxisome biogenesis disorder, complementation group 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9812896" TraitType="Disease" MappingType="XRef" MappingValue="614870" MappingRef="OMIM">
        <MedGen CUI="C3553947" Name="Peroxisome biogenesis disorder 6A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

